Moneycontrol PRO
LAMF
LAMF

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Glenmark, Dr Reddy's top picks: R Sreesankar

  • Buy Glenmark Pharma, advises Sudarshan Sukhani

  • Prefer textile, pharma, IT space: Deepak Shenoy

  • Buy SBI Canara Bank, Glenmark, Jubilant Food: Sukhani

  • Go long in Glenmark, Aurobindo Pharma: Ashish Chaturmohta

  • Ajay Bodke positive on Glenmark Pharma; target Rs 1186

  • Here are top 10 stocks to focus on April 20

  • See 10-15% upside in midcap pharma space: Vineet Bhatnagar

  • Glenmark can outperform, target Rs 1180-1200: TS Harihar

  • Prefer Glenmark Pharma: Tushar Mahajan

  • Buy Glenmark, Colgate Palmolive: Sudarshan Sukhani

  • Here are top 10 stocks to focus on April 15

  • Alzheimer drug nod won't impact Lupin, Glenmark: Expert

  • Buy Glenmark Pharma, advises Sudarshan Sukhani

  • Buy Glenmark Pharma, Bharat Forge, HPCL: Sudarshan Sukhani

  • Buy Glenmark Pharma, says Deepak Shenoy

  • Top buzzing midcap stocks to trade on April 8

  • Buy Glenmark Pharma, says Sudarshan Sukhani

  • Buy Idea Cellular, Divis Labs, Glenmark: Manish Hathiramani

  • Look at Prism Cement: Dilip Bhat

  • Buy Glenmark Pharma 860 Call; sell 880 Call: VK Sharma

  • Buy Glenmark Pharma 860 Call: Gaurav Bissa

  • Go long in Glenmark Pharma, says Ashish Chaturmohta

  • Glenmark Pharma may test Rs 900-920: Amit Gupta

  • Prefer Glenmark Pharma, Suven Lifesciences: Prakash Diwan

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347